Adverse events524

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 524

Type	Event	Organ system	Group	Affected	At risk
other	Acne	Skin and subcutaneous tissue disorders	Dasatinib, 100/140 mg QD	0	3
other	Acne	Skin and subcutaneous tissue disorders	Dasatanib, 100/140 mg QD + BMS-833923, 50 mg QD	2	8
other	Acne	Skin and subcutaneous tissue disorders	Dasatanib, 100/140 mg QD + BMS-833923, 100 mg BID/QD	0	14
other	Acne	Skin and subcutaneous tissue disorders	Dasatinib, 100 /140 mg QD+ BMS-833923, 200 mg BID/QD	0	2
other	Amylase	Investigations	Dasatinib, 100/140 mg QD	0	3
other	Amylase	Investigations	Dasatanib, 100/140 mg QD + BMS-833923, 50 mg QD	2	8
other	Amylase	Investigations	Dasatanib, 100/140 mg QD + BMS-833923, 100 mg BID/QD	0	14
other	Amylase	Investigations	Dasatinib, 100 /140 mg QD+ BMS-833923, 200 mg BID/QD	0	2
other	Amylase increased	Investigations	Dasatinib, 100/140 mg QD	0	3
other	Amylase increased	Investigations	Dasatanib, 100/140 mg QD + BMS-833923, 50 mg QD	2	8
other	Amylase increased	Investigations	Dasatanib, 100/140 mg QD + BMS-833923, 100 mg BID/QD	0	14
other	Amylase increased	Investigations	Dasatinib, 100 /140 mg QD+ BMS-833923, 200 mg BID/QD	0	2
other	Arthralgia	Musculoskeletal and connective tissue disorders	Dasatinib, 100/140 mg QD	0	3
other	Arthralgia	Musculoskeletal and connective tissue disorders	Dasatanib, 100/140 mg QD + BMS-833923, 50 mg QD	0	8
other	Arthralgia	Musculoskeletal and connective tissue disorders	Dasatanib, 100/140 mg QD + BMS-833923, 100 mg BID/QD	3	14
other	Arthralgia	Musculoskeletal and connective tissue disorders	Dasatinib, 100 /140 mg QD+ BMS-833923, 200 mg BID/QD	0	2
other	Constipation	Gastrointestinal disorders	Dasatinib, 100/140 mg QD	0	3
other	Constipation	Gastrointestinal disorders	Dasatanib, 100/140 mg QD + BMS-833923, 50 mg QD	1	8
other	Constipation	Gastrointestinal disorders	Dasatanib, 100/140 mg QD + BMS-833923, 100 mg BID/QD	4	14
other	Constipation	Gastrointestinal disorders	Dasatinib, 100 /140 mg QD+ BMS-833923, 200 mg BID/QD	0	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01218477/events

API reference For AI assistants

Adverse events524

Sources 3

Read this list from software.